Central neuraxial blockade for splenectomy in myeloproliferative disease: A word of caution.

Abstract

We describe management of portal vein thrombosis (PVT) in a patient with myeloproliferative disease after splenectomy. This case posed a unique therapeutic challenge in maintaining a fine balance between life-saving thrombolysis and the risk of neuraxial complications due to bleeding. The incidence of PVT after splenectomy in patients with myeloproliferative disorders is high (40%). Anaesthesiologists should be aware of this and avoid central neuraxial blockade in such cases. If post-operative emergency thrombolysis is required in a patient having an epidural catheter in situ, it should be done under close monitoring, weighing the risks and benefits. Fibrinogen levels should be monitored to evaluate the presence of residual thrombolytic effects and to time the catheter removal.

• Authors: S N Myatra, A Kothekar, S S Siddiqui, J V Divatia
• Journal: Indian journal of anaesthesia (Indian J Anaesth) Vol. 59 Issue 10 Pg. 670-2 (Oct 2015) ISSN: 0019-5049 [Print] India
• PMID: 26644616 (Publication Type: Journal Article)